U.S., May 2 -- ClinicalTrials.gov registry received information related to the study (NCT06953596) titled 'Transcranial Magnetic Stimulation to Treat Prolonged Grief Disorder' on April 22.
Brief Summary: Grief is a normal response after the death of a loved one. With time, the grief response decreases and people learn to cope with their loss. However, for some, the response becomes more intense and distressing. This is called prolonged grief disorder (PGD). People with PGD experience emotional pain and a deep longing for their loved one. PGD normally occurs <10% of people after a loss, but it has become more common since the COVID-19 pandemic (~30%). If left untreated, PGD leads to poor quality of life and increased risk of death. Treatmen...